by American Society of Nephrology Credit: Pixabay/CC0 Public Domain Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests that...
Tag: <span>anti-cancer therapies</span>
Post
Building stronger anti-cancer therapies with stem cells
by Kyoto University Graphical abstract. Credit: DOI: 10.1016/j.ymthe.2021.05.016 Cancer therapies have seen great development over the decades. Radiotherapies and chemotherapies have saved countless lives, but the latest arsenal, adoptive cell therapies (ACT), has stirred most excitement. In ACT, cells are processed to enhance their anti-cancer immune effects and injected into the patient. A new study by...